Aschman T, Schaffer S, Biniaris Georgallis S, Triantafyllopoulou A, Staeheli P, Voll R
Int J Mol Sci. 2021; 22(21).
PMID: 34769174
PMC: 8584021.
DOI: 10.3390/ijms222111747.
Stypinska B, Paradowska-Gorycka A
Int J Mol Sci. 2015; 16(10):24194-218.
PMID: 26473848
PMC: 4632746.
DOI: 10.3390/ijms161024194.
You M, Dong G, Li F, Ma F, Ren J, Xu Y
Cell Mol Immunol. 2015; 14(2):192-202.
PMID: 26277892
PMC: 5301152.
DOI: 10.1038/cmi.2015.61.
Holmes D, Suto E, Lee W, Ou Q, Gong Q, Smith H
J Exp Med. 2015; 212(7):1081-93.
PMID: 26077719
PMC: 4493413.
DOI: 10.1084/jem.20142130.
Kiefer K, Oropallo M, Cancro M, Marshak-Rothstein A
Immunol Cell Biol. 2012; 90(5):498-504.
PMID: 22430248
PMC: 3701256.
DOI: 10.1038/icb.2012.10.
Dendritic cells in systemic lupus erythematosus.
Seitz H, Matsushima G
Int Rev Immunol. 2010; 29(2):184-209.
PMID: 20367140
PMC: 2892226.
DOI: 10.3109/08830181003602507.
Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery.
Gordon J, Magro C, Lu T, Schneider R, Chiu A, Furman R
HSS J. 2009; 5(2):169-77.
PMID: 19609622
PMC: 2744761.
DOI: 10.1007/s11420-009-9123-x.
New roles for the major human 3'-5' exonuclease TREX1 in human disease.
Kavanagh D, Spitzer D, Kothari P, Shaikh A, Liszewski M, Richards A
Cell Cycle. 2008; 7(12):1718-25.
PMID: 18583934
PMC: 2825026.
DOI: 10.4161/cc.7.12.6162.
Association of interferon-gamma gene polymorphism (+874A) with arthritis manifestation in SLE.
Tangwattanachuleeporn M, Sodsai P, Avihingsanon Y, Wongpiyabovorn J, Wongchinsri J, Hirankarn N
Clin Rheumatol. 2007; 26(11):1921-4.
PMID: 17713715
DOI: 10.1007/s10067-007-0699-6.
Dendritic cells and the immunopathogenesis of systemic lupus erythematosus.
Monrad S, Kaplan M
Immunol Res. 2007; 37(2):135-45.
PMID: 17695248
DOI: 10.1007/BF02685895.
Controversies in lupus: nervous system involvement.
Bruyn G
Ann Rheum Dis. 1995; 54(3):159-67.
PMID: 7748011
PMC: 1005546.
DOI: 10.1136/ard.54.3.159.
Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications.
Lebon P, Lenoir G, Fischer A, Lagrue A
Br Med J (Clin Res Ed). 1983; 287(6400):1165-7.
PMID: 6414612
PMC: 1549458.
DOI: 10.1136/bmj.287.6400.1165.
Glomerular response to immunologic injury, studies on progression.
Killen P, Melcion C, Bonadio J, MOREL-MAROGER L, Striker G
Springer Semin Immunopathol. 1982; 5(3):297-320.
PMID: 6191400
DOI: 10.1007/BF01892090.
Lymphocytic choriomeningitis infection in the nude mouse. An immunopathological study.
Ronco P, Riviere Y, Thoua Y, Bandu M, GUILLON J, Verroust P
Immunology. 1981; 43(4):763-70.
PMID: 6168566
PMC: 1555081.
Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis.
Pelton B, DENMAN A
Ann Rheum Dis. 1985; 44(3):143-7.
PMID: 3872101
PMC: 1001593.
DOI: 10.1136/ard.44.3.143.
[Detection of nephrotoxicity of human alpha 2b interferon with special reference to the analysis of urine enzymes in patients with chronic myeloid leukemia].
Kurschel E, Hofmann W, Niederle N
Klin Wochenschr. 1987; 65(14):667-72.
PMID: 3476805
DOI: 10.1007/BF01875502.
Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.
von Wussow P, Jakschies D, Hartung K, Deicher H
Rheumatol Int. 1988; 8(5):225-30.
PMID: 3266358
DOI: 10.1007/BF00269199.
Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.
Passwell J, Schreiner G, Nonaka M, Beuscher H, Colten H
J Clin Invest. 1988; 82(5):1676-84.
PMID: 3183062
PMC: 442737.
DOI: 10.1172/JCI113780.
The potential role of interferons and interferon antagonists in inflammatory disease.
Heremans H, Billiau A
Drugs. 1989; 38(6):957-72.
PMID: 2482167
DOI: 10.2165/00003495-198938060-00007.
Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.
Tovey M
Experientia. 1989; 45(6):526-35.
PMID: 2472287
DOI: 10.1007/BF01990502.